Literature DB >> 25323588

Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy.

D J Roberts1, S Miyamoto1.   

Abstract

Accumulating evidence reveals that metabolic and cell survival pathways are closely related, sharing common signaling molecules. Hexokinase catalyzes the phosphorylation of glucose, the rate-limiting first step of glycolysis. Hexokinase II (HK-II) is a predominant isoform in insulin-sensitive tissues such as heart, skeletal muscle, and adipose tissues. It is also upregulated in many types of tumors associated with enhanced aerobic glycolysis in tumor cells, the Warburg effect. In addition to the fundamental role in glycolysis, HK-II is increasingly recognized as a component of a survival signaling nexus. This review summarizes recent advances in understanding the protective role of HK-II, controlling cellular growth, preventing mitochondrial death pathway and enhancing autophagy, with a particular focus on the interaction between HK-II and Akt/mTOR pathway to integrate metabolic status with the control of cell survival.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25323588      PMCID: PMC4291497          DOI: 10.1038/cdd.2014.173

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  178 in total

1.  Functional organization of mammalian hexokinases: both N- and C-terminal halves of the rat type II isozyme possess catalytic sites.

Authors:  H J Tsai; J E Wilson
Journal:  Arch Biochem Biophys       Date:  1996-05-01       Impact factor: 4.013

2.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

3.  Heart muscle hexokinase: subcellular distribution and inhibition by glucose 6-phosphate.

Authors:  S E Mayer; A C Mayfield; J A Haas
Journal:  Mol Pharmacol       Date:  1966-09       Impact factor: 4.436

Review 4.  Therapeutic targets in cancer cell metabolism and autophagy.

Authors:  Heesun Cheong; Chao Lu; Tullia Lindsten; Craig B Thompson
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

5.  Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.

Authors:  Peter L Pedersen; Saroj Mathupala; Annette Rempel; J F Geschwind; Young Hee Ko
Journal:  Biochim Biophys Acta       Date:  2002-09-10

6.  Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding.

Authors:  E Bustamante; H P Morris; P L Pedersen
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

Review 7.  Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?

Authors:  A W Tong; J Nemunaitis
Journal:  Cancer Gene Ther       Date:  2008-03-28       Impact factor: 5.987

Review 8.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

9.  Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death.

Authors:  Christopher P Baines; Robert A Kaiser; Tatiana Sheiko; William J Craigen; Jeffery D Molkentin
Journal:  Nat Cell Biol       Date:  2007-04-08       Impact factor: 28.824

10.  Cardiac-specific hexokinase 2 overexpression attenuates hypertrophy by increasing pentose phosphate pathway flux.

Authors:  Kyle S McCommis; Diana L Douglas; Maike Krenz; Christopher P Baines
Journal:  J Am Heart Assoc       Date:  2013-11-04       Impact factor: 5.501

View more
  133 in total

1.  Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation.

Authors:  Karen Bernard; Naomi J Logsdon; Saranya Ravi; Na Xie; Benjamin P Persons; Sunad Rangarajan; Jaroslaw W Zmijewski; Kasturi Mitra; Gang Liu; Victor M Darley-Usmar; Victor J Thannickal
Journal:  J Biol Chem       Date:  2015-08-28       Impact factor: 5.157

2.  Kaempferol Induces Cell Death and Sensitizes Human Head and Neck Squamous Cell Carcinoma Cell Lines to Cisplatin.

Authors:  Mabel Catalán; Catalina Rodríguez; Ivonne Olmedo; Javiera Carrasco-Rojas; Diego Rojas; Alfredo Molina-Berríos; Mario Díaz-Dosque; José A Jara
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia.

Authors:  Nina Fenouille; Christopher F Bassil; Issam Ben-Sahra; Lina Benajiba; Gabriela Alexe; Azucena Ramos; Yana Pikman; Amy S Conway; Michael R Burgess; Qing Li; Frédéric Luciano; Patrick Auberger; Ilene Galinsky; Daniel J DeAngelo; Richard M Stone; Yi Zhang; Archibald S Perkins; Kevin Shannon; Michael T Hemann; Alexandre Puissant; Kimberly Stegmaier
Journal:  Nat Med       Date:  2017-02-13       Impact factor: 53.440

4.  Functional diversification of the NleG effector family in enterohemorrhagic Escherichia coli.

Authors:  Dylan Valleau; Dustin J Little; Dominika Borek; Tatiana Skarina; Andrew T Quaile; Rosa Di Leo; Scott Houliston; Alexander Lemak; Cheryl H Arrowsmith; Brian K Coombes; Alexei Savchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-14       Impact factor: 11.205

5.  Octamer transcription factor-1 induces the Warburg effect via up-regulation of hexokinase 2 in non-small cell lung cancer.

Authors:  Zhen Li; Jin Su; Mingming Sun; Jiaqi Song; Huanran Sun; Jun Fan; Guo Chen; Changliang Shan; Qi Qi; Shuai Zhang
Journal:  Mol Cell Biochem       Date:  2021-05-10       Impact factor: 3.396

Review 6.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

7.  Anabolism-Associated Mitochondrial Stasis Driving Lymphocyte Differentiation over Self-Renewal.

Authors:  William C Adams; Yen-Hua Chen; Radomir Kratchmarov; Bonnie Yen; Simone A Nish; Wen-Hsuan W Lin; Nyanza J Rothman; Larry L Luchsinger; Ulf Klein; Meinrad Busslinger; Jeffrey C Rathmell; Hans-Willem Snoeck; Steven L Reiner
Journal:  Cell Rep       Date:  2016-12-20       Impact factor: 9.423

8.  Shikonin, vitamin K3 and vitamin K5 inhibit multiple glycolytic enzymes in MCF-7 cells.

Authors:  Jing Chen; Xun Hu; Jingjie Cui
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

Review 9.  Everolimus and sirolimus in transplantation-related but different.

Authors:  Jost Klawitter; Björn Nashan; Uwe Christians
Journal:  Expert Opin Drug Saf       Date:  2015-04-26       Impact factor: 4.250

Review 10.  Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases.

Authors:  Juan Li; Tongxin Wang; Jun Xia; Weilei Yao; Feiruo Huang
Journal:  FASEB J       Date:  2019-08-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.